StemCell Therapy

- Pharmaceutical Contract Manufacturing Market 2019-2029

- Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages

LONDON, Oct. 21, 2019 /PRNewswire/ -- The pharmaceutical contract manufacturing market is expected to grow at a CAGR of 5.7% in the first half of the forecast period. The API Manufacturing submarket held 67% of the market in 2018. Visiongain estimated that the pharmaceutical contract manufacturing market will reach $138bn in 2024.

How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 231-page report you will receive 73 tables and 55 figures all unavailable elsewhere.

The 231-page Visiongain report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/pharmaceutical-contract-manufacturing-market-2019-2029/#download_sampe_div

Report Scope

Global Pharmaceutical Contract Manufacturing Market forecasts from 2019-2029

Submarket forecasts at world level, from 2019-2029: Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types Other applications of outsourced production other related services

Revenue forecasts from 2019-2029, for these regional and national markets: The US Canada Japan EU5: Germany, France, the UK, Italy and Spain BRIC: Brazil, Russia, India, China South Korea Turkey Mexico Others

Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry

Qualitative Analysis from a CMO Perspective

Qualitative Analysis from a Client Perspective

Key questions answered by this report: What is the current size of the total global pharmaceutical contract manufacturing market? How much will this market be worth from 2018 to 2029? How is the pharmaceutical contract manufacturing market evolving? What is driving and restraining the pharmaceutical contract manufacturing market? What are the market shares of each segment of the overall pharmaceutical contract manufacturing market currently and how will these change to 2029? What are the main submarkets and how much revenue will each pharmaceutical contract manufacturing submarket account for over the next 10 years to 2029 and why? How will the market shares for each pharmaceutical contract manufacturing submarket develop from 2018 to 2029? Who are the leading players and what are their prospects over the forecast period? How will the industry evolve to 2029? What are the largest national markets for pharmaceutical contract manufacturing? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029? Who are the most prominent companies, and what are their activities and outlooks? What are the main trends that will affect the pharmaceutical contract manufacturing market between 2018 and 2029?

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/pharmaceutical-contract-manufacturing-market-2019-2029/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

AbbVieActavisADC BiotechnologyAegerion PharmaceuticalsAenova GroupAesica PharmaAgensysAgila SpecialtiesAjinomoto Althea IncAlexion PharmaceuticalsAlmac GroupAlthea TechnologiesAMRI (Albany Molecular Research Inc)API Corporation (APIC)Aspen PharmacareAstellasAstraZenecaBanner Life SciencesBanner PharmacapsBaring Private Equity AsiaBausch & LombBayer HealthcareBen Venue LaboratoriesBend ResearchBiogen IdecBioIndustry Association (BIA)BiotestBlackstone GroupBoehringer IngelheimBoehringer Ingelheim BioXcellenceBristol-Myers Squibb CompanyBushu PharmaceuticalsCambrexCambridge Major LaboratoriesCatalent Pharma SolutionsCedarburg HauserCell Therapy CatapultCelldex TherapeuticsCelltrionCenexiChemisch-Pharmazeutisches Laboratorium RavensburgChemtrixChina FDA (CFDA)CiplaCook PharmicaCordenPharmaCTC BioDaito PharmaceuticalDelpharmDishman PharmaceuticalsDPx Fine ChemicalsDPx Holdings B.V.Dr. Reddy's LaboratoriesDSP (DSM Sinochem Pharmaceuticals)EisaiEli LillyEsteve QuimicaEuticalsEvonik DegussaFamarFarevaFUJIFILM Diosynth Biotechnologies,Gallus Biopharmaceutical, LLC.G-CONGEA Pharma-SystemsGenentechGlaxoSmithKline (GSK)Granules IndiaHaupt PharmaHexalHospiraHospira One2OneImmunoGenImmunomedicsIndian Pharmaceutical AllianceInnovent BiologicsIRIX PharmaceuticalsJanssenJK PharmaceuticalJohnson & JohnsonKnowledge Transfer Network (KTN)LonzaLupinMarinopoulos GroupMatrix LaboratoriesMediceMedichemMerck & Co.Micron TechnologiesMillenniumMitsui & CoMomenta PharmaceuticalsMylanNeuland LaboratoriesNICE InsightNPS PharmaceuticalsNycomedOrchid Chemicals & PharmaceuticalsOxford BiomedicaPatheonPatheon BiologicsPfizerPharmapak TechnologiesPiramal Pharma SolutionsProgenicsQuintilesRecepta BiopharmaRecipharmRedwood BioscienceRentschler BiotechnologieRocheRoyal DSMSAFCSafeBridgeSamsung BioepisSamsung BioLogicsSandozSanofiSeattle GeneticsShandong XinhuaShangPharmaShireSiegfried AGSigmar ItaliaSMS PharmaceuticalsSolvias AGSpeedelStadaStem CentRxStevenage Bioscience CatalystTakedaTemmler GroupTeva APIThermo Fisher ScientificUMN PharmaUNIGENValeant PharmaceuticalsValerion Therapeutics, LLC.Vetter Pharma-Fertigung GmbHVivante GMP SolutionsWest Pharmaceutical ServicesWuXi PharmaTechZhangjiang Biotech & Pharmaceutical Base CompanyZhejiang Jiang Yuan Tang Biotechnology

List or Organizations Mentioned in the ReportAgncia Nacional de Vigilncia Sanitria (ANVISA)Asociacin Espaola de Fabricantes de Productos de Qumica Fina (AFAQUIM)Associao Brasileira da Indstria Farmoqumica e de Insumos Farmacuticos (ABIQUIFI)Association of British Pharmaceutical Industry (ABPI)Central Drugs Standard Control Organization (CDSCO)Department of Health and Family WelfareDevelopment and Reform Commission (NDRC)European CommissionEuropean Medicines Agency (EMA)Food and Drug Administration (US FDA)Indian Drug Manufacturer's Association (IDMA)International Society of Pharmaceutical Engineering (IPSE)Korea Food and Drug Administration (KFDA)Korea Pharmaceutical Manufacturer's Association (KPMA)Medicines and Healthcare Products Regulatory Agency (MHRA)Medicines Manufacturing Industry Partnership (MMIP)Ministry of Health (MOH)Ministry of Health, Labor and Welfare (MHLW)Ministry of Industry and Information Technology (MIIT)Pharmaceutical and Medical Devices Agency (PMDA)World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029

Global Medical Device Contract Manufacturing Market Forecast 2019-2029

Top 30 Pharmaceutical Wholesale & Distribution Organizations 2019

Generic Drugs Market Forecast 2019-2029

Checkpoint Inhibitors for Anti-Cancer Treatment Market 2019-2029

Top 30 Oncology Drugs Manufacturers 2019

Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

Continued here:
Visiongain Report Researches Growth Opportunities Within the $138bn Pharmaceutical Contract Manufacturing Market - P&T Community

This entry was posted on October 21, 2019 at 10:44 am and is filed under Molecular Genetics. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |